Trials / Terminated
TerminatedNCT02716896
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer: A Pilot, Randomized-Controlled Non-Inferiority Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
Currently the standard treatment of muscle invasive bladder cancer is the complete removal of bladder and adjacent organs, such as prostate or ovaries. Radical cystectomy is fraught with complications and risk of death. The researchers hope to learn if chemoradiation (i.e. using chemotherapy and radiation), also an acceptable treatment for muscle invasive bladder cancer, can be used a good alternative therapy option.
Detailed description
Currently the standard treatment of muscle invasive bladder cancer is the complete removal of bladder and adjacent organs, such as prostate or ovaries. Such procedure is highly invasive and undesirable for some patients. The researchers hope to learn if chemoradiation, using chemotherapy and radiation, can be a good alternative therapy option. Chemoradiation therapy is also currently considered an acceptable clinical approach but is typically used for treatment in patients with muscle invasive bladder cancer who have other medical issues that might cause complications during or after undergoing surgery. Disease free survival at 5 years is better for those who had their bladder removed, but overall survival rates for chemoradiation therapy patients are comparable between the two approaches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiation and chemoradiation | Radiation and chemotherapy will be administered concurrently to those who are randomized to this group. |
| PROCEDURE | Radical cystectomy | Radical cystectomy will be performed on those who are randomized to this group. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-03-26
- Completion
- 2018-03-26
- First posted
- 2016-03-23
- Last updated
- 2019-11-25
- Results posted
- 2019-11-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02716896. Inclusion in this directory is not an endorsement.